Information Provided By: 
Fly News Breaks for March 28, 2019
ALGN
Mar 28, 2019 | 21:05 EDT
Piper Jaffray analyst Matt O'Brien kept his Overweight rating and $300 price target on Align Technology after its announced settlement agreement with Straumann Group on a patent dispute going on for multiple years. The analyst sees the development as a positive for Align Technology as it removes the litigation expense and also allows the company to "tap into Straumann's significant distribution in Europe."
News For ALGN From the Last 2 Days
ALGN
Apr 18, 2024 | 07:23 EDT
Stifel raised the firm's price target on Align Technology to $400 from $350 and keeps a Buy rating on the shares. Respondents to the firm's survey point to "solid" 2024 year-over-year case volume growth and while Invisalign's share is expected to step down "modestly" year-over-year, new product feedback is upbeat, says the firm, which adds that it has "an upside bias to our 2024 revenue estimate."
